[Form 4] Chemours Co Insider Trading Activity

Rhea-AI Filing Summary

Courtney Mather, a director of Chemours Co (CC), reported acquisition of deferred stock units tied to common shares on 09/30/2025. The Form 4 shows 1,657 deferred stock units were acquired at a reported unit value of $15.84 each. Each deferred stock unit is the economic equivalent of one share of common stock and becomes payable after the director leaves board service. After the reported transaction the filing indicates the reporting person beneficially owns 3,960.9731 shares in a direct ownership form.

Positive

• Director equity alignment: Acquisition of 1,657 deferred stock units ties compensation to company share performance
• Transparent disclosure: Form 4 reports transaction details including unit count, unit value ($15.84), and post-transaction beneficial ownership (3,960.9731 shares)

Negative

• None.

Insights

Financial Analyst

TL;DR: Routine equity award increases directors stake modestly; not a material corporate event.

The reported acquisition of 1,657 deferred stock units at $15.84 per unit represents a standard director compensation settlement rather than an open-market purchase. Deferred stock units convert economically to common shares upon termination of service, aligning the directors interests with long-term shareholder value. The total direct beneficial ownership after the transaction is 3,960.9731 shares, which appears modest relative to a public companys outstanding float and therefore unlikely to move valuation or change control considerations.

Corporate Governance Expert

TL;DR: Typical board compensation mechanism that reinforces retention and alignment without signaling material governance change.

Deferred stock units payable after service termination are common for non-employee directors and serve retention and alignment objectives. The Form 4 disclosures are straightforward and provide required transparency about timing, amount (1,657 units), and the conversion equivalence to common shares. No change in director status, ownership structure, or new governance arrangements is disclosed in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

MATHER COURTNEY

(Last) (First) (Middle)

C/O THE CHEMOURS COMPANY

1007 MARKET STREET

(Street)

WILMINGTON DE 19801

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Chemours Co [ CC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Deferred Stock Units	(1)	09/30/2025		A		1,657		(1)	(1)	Common Stock	1,657	$15.84	3,960.9731	D

Explanation of Responses:

1. Each deferred stock unit is the economic equivalent of one share of the Issuer's common stock. The deferred stock units become payable upon the first month following the Reporting Person's termination of service as a director.

	/s/ Eric Stein, Attorney-in-Fact	10/02/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Chemours director Courtney Mather report on Form 4 (CC)?

The Form 4 reports acquisition of 1,657 deferred stock units on 09/30/2025, at a reported unit value of $15.84.

What are deferred stock units reported on the Form 4 for CC?

Each deferred stock unit is the economic equivalent of one share of Chemours common stock and becomes payable after the directors termination of service.

How many shares does Courtney Mather beneficially own after the reported transaction?

The filing indicates 3,960.9731 shares are beneficially owned in a direct form following the reported transaction.

Does this Form 4 indicate any change in director status for CC?

No. The filing identifies the reporting person as a director and does not disclose any resignation, appointment, or other change in status.

Is the reported transaction likely to be material to Chemours (CC) investors?

The filing describes a routine director compensation settlement; based on disclosed amounts it appears not materially impactful to company control or valuation.